Metro Healthcare Indonesia Tbk. vs Citra Nusantara Gemilang Tbk. — how do they compare? Metro Healthcare Indonesia Tbk. trades at Rp430 (market cap 14.23T, 7.3K 24h volume), while Citra Nusantara Gemilang Tbk. trades at Rp153 (market cap 272.81B, 381.8K 24h volume). The key difference: Metro Healthcare Indonesia Tbk. is far larger — about 52.2× Citra Nusantara Gemilang Tbk.'s market cap, and Citra Nusantara Gemilang Tbk. is more actively traded (381.8K versus 7.3K). Which is the better fit depends on your goals.
| CARE | CGAS | |
|---|---|---|
Market Cap | 14.23T | 272.81B |
Volume | 7.3K | 381.8K |
Lot | 73 | 3.82K |
Turnover | 3.14M | 58.55M |
Average Price | 429.95 | 153.35 |
Value | 3.14M | 58.55M |
Indicative Equilibrium Price | 428 | 154 |
Indicative Equilibrium Volume | 400 | 94.2K |
Trailing returns across standard periods
Latest headlines on both assets
PT Metro Healthcare Indonesia Tbk (the “Company”) was established under the name PT Aruna Anjaya Perkasa, based on Notarial Deed No. 67 dated October 07, 2015 of Humberg Lie, S.H., S.E., M.Kn notary in Jakarta. The Company started its commercial operations in 2016 .
Read more on CARE →PT Citra Nusantara Gemilang Tbk (the “Company”), was established based on Notarial Deed No. 22, dated December 21, 2005 of Edi Priyono, S.H.. The Company's parent entity is PT Petro Asia Energy
Read more on CGAS →